Christopher B. Fox
11Patents
1h-index
20Co-inventors
46Inventor score
Filing activity: Feb 7, 2013 → Dec 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11141377B2 | Nanostructured lipid carriers and stable emulsions and uses thereof | Emerging Cross-Sectional Technologies | 17 | Active |
| US12318436B2 | Composition and method for spray drying an adjuvant vaccine emulsion | Emerging Cross-Sectional Technologies | 0 | Active |
| US11344619B2 | Formulation containing TLR agonist and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12318484B2 | Pegylated liposomes and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11801223B2 | Single vial vaccine formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US11510875B2 | Adjuvant formulations comprising TLR4 agonists and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US12427116B2 | Nanoalum particles containing a pegylated lipid sizing agent | Performing Operations; Transporting | 0 | Active |
| US11266602B2 | PEGylated liposomes and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
| US12285483B2 | Solanesol vaccine adjuvants and methods of preparing same | Human Necessities | 0 | Active |
| US11173126B2 | Nanoalum particles comprising a PAA sizing agent | Performing Operations; Transporting | 0 | Active |
| US12201722B2 | Nanostructured lipid carriers and stable emulsions and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.